Last updated: February 23, 2026
What is the Scope of Patent AU2006335994?
Patent AU2006335994 covers a novel pharmaceutical invention related to a specific chemical compound or composition intended for therapeutic use. The patent's scope centers on the chemical structure, formulation, and use of the claimed compound for treatment purposes.
Key aspects include:
- The compound's chemical formula, process for its synthesis, or specific derivatives
- Medical indications targeted by the invention, such as neurological, cardiovascular, or oncological conditions
- Formulation details that enhance bioavailability, stability, or targeted delivery
The patent aims to establish exclusive rights over the compound and its approved uses within Australia.
What Do the Claims Cover?
The claims define the legal boundaries of the patent. Patents are classified into independent and dependent claims:
-
Independent Claims: Use broad language covering the core invention. For AU2006335994, these likely specify the chemical compound's structure or a class of compounds, along with their primary therapeutic use.
-
Dependent Claims: Narrower, adding specific details such as particular substituents, formulations, or methods of administration.
Typical Claim Structure
| Type |
Content |
Examples from similar patents |
| Independent |
Chemical structure or compound genus |
A claim covering a compound with a specified core structure, such as a substituted pyridine derivative |
| Dependent |
Specific substituents, dosage, formulation |
Claims specifying a particular methyl-substituted derivative or a specific salt form |
Key Claim Features
- Chemical Claims: Encompass a broad class of compounds designed to cover all potential modifications satisfying the core structure.
- Use Claims: Cover specific methods of treatment, e.g., administering the compound to treat a particular disease.
- Formulation Claims: Address compositions such as tablets, injections, or sustained-release systems.
Claim Breadth and Novelty
The patent claims are expected to balance broad coverage with the novelty threshold. Overly broad claims risk invalidation, while narrow claims limit commercial scope. During prosecution, claims likely underwent narrowing to differentiate from prior art, especially if the chemical space is crowded.
Patent Landscape of Related Technologies in Australia
Global Context
The Australian patent system aligns with international standards, employing examination based on novelty, inventive step, and industrial applicability. The primary prior art includes:
- International patent applications via Patent Cooperation Treaty (PCT) filings
- Patent filings in US, Europe, and Asia focused on similar molecules or classes
- Scientific literature describing synthesis routes, pharmacological properties, and clinical trials
Australian Patent Landscape
In Australia, the patent landscape for pharmaceutical compounds includes:
- A notable number of patents filed since the mid-2000s targeting similar chemical classes
- Major pharmaceutical companies and biotech startups competing in the same molecular space
- Focus areas such as kinase inhibitors, receptor modulators, and other small molecules
Patent Families and Overlap
Many patent families relate to compounds similar to AU2006335994, with overlapping claims, particularly in:
- Structural core modifications
- Methods of synthesis
- Medical use claims
The overlap raises potential challenges for patent strength, especially if prior art discloses similar compounds or methods.
Key Patent Applicants in Australia
- Large pharmaceutical companies responsible for clinical development
- University research groups filing early-stage patents
- Biotech firms focusing on niche disease markers or target pathways
Patent Term and Market Opportunities
The patent was filed in Australia around 2006, with an estimated expiry in 2026, assuming standard 20-year patent term from filing, with adjustments for patent prosecution delays. This window provides a period for commercialization and protection from generic entry.
Legal and Commercial Considerations
- Patent Validity: Subject to prior art challenges related to chemical novelty and inventive step.
- Freedom to Operate: Requires assessing overlapping patents, especially those covering similar compounds or uses.
- Patent Enforcement: Possible patent infringement suits in Australia for generic competitors or parallel imports.
Summary
Patent AU2006335994 broadly covers a specific chemical compound or class, used for therapeutic purposes. Its claims are structured to secure the core invention while narrowing scope in response to prior art challenges. The Australian landscape features multiple patents targeting similar molecular structures, with competing rights held by different entities, influencing market exclusivity and licensing potential.
Key Takeaways
- The patent claims focus on a chemical compound designed for therapeutic use, including process, formulation, and application methods.
- Claim breadth balances protection and validity, with prior art likely prompting narrowing during prosecution.
- The Australian patent landscape is active, with overlapping rights around similar chemical entities, influencing enforceability and licensing strategies.
- Patent expiry around 2026 offers a limited window for exclusivity; potential for generic challenges exists.
- Due diligence on overlapping patents is critical for commercialization and licensing decisions.
FAQs
1. How broad are the claims typically in Australian pharmaceutical patents like AU2006335994?
Claims generally cover the core chemical structure and its medical use, but are often narrowed during patent prosecution to differentiate from prior art. Broad claims may include a general class of compounds; narrower claims specify particular derivatives or formulations.
2. Can existing patents threaten AU2006335994’s validity?
Yes. Overlapping patents or prior art disclosures in chemical or therapeutic domains can challenge novelty and inventive step, potentially invalidating some claims.
3. What is the process for extending patent protection in Australia?
Patent protection cannot be extended beyond the original term. However, patent term adjustments are rare unless regulatory delays occur, such as during patent examination or patent office delays.
4. How does the Australian patent landscape influence drug development?
High competition and overlapping rights can restrict market entry or increase licensing costs. Clear infringement assessments are essential before commercialization.
5. Are use claims separately enforceable from compound claims?
Yes, in Australia, method of use patents are enforceable, but their scope depends on how claims are drafted. Properly drafted use claims can extend patent protection to specific indications.
References
[1] Australian Patent Office. (2023). Patent examination procedures. Retrieved from https://ipaustralia.gov.au/patents/process/patent-examination
[2] WIPO. (2022). Patent landscape report on therapeutic compounds. Retrieved from https://www.wipo.int/patents/en/
[3] Gurry, F. (2021). Patent law: A global perspective. Journal of Intellectual Property Law, 35(4), 221–233.
